Stay updated on Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded a consolidated Locations section with expanded study sites across multiple US states and other countries, and removed the previous per-state location entries (and the HHS Vulnerability Disclosure link) to streamline navigation.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded an explanatory note that publications are automatically filled in from PubMed and included the revision label 'v3.3.2'; the prior PubMed-related wording and the older revision 'v3.2.0' have been removed.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the government funding lapse banner, which did not affect core study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedThe screenshots show only minor layout and formatting adjustments; the core study data (title, NCT03657043, conditions, eligibility criteria, outcomes, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedAdded a Publications section citing a new PubMed article (new core content and proper nouns) with a full bibliographic reference; no deletions present.SummaryDifference2%

- Check83 days agoChange Detected- Added a government funding lapse notice and operating status guidance, and a new version tag (v3.2.0). - Removed the previous version tag (v3.1.0).SummaryDifference2%

Stay in the know with updates to Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.